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Padanamides are linear tetrapeptides notable for the
absence of proteinogenic amino acids in their struc-
tures. In particular, two unusual heterocycles, (S)-
3-amino-2-oxopyrrolidine-1-carboxamide (S-Aopc)
and (S)-3-aminopiperidine-2,6-dione (S-Apd), are
found at the C-termini of padanamides A and B,
respectively. Here we identify the padanamide
biosynthetic gene cluster and carry out systematic
gene inactivation studies. Our results show that
padanamides are synthesized by highly dissociated
hybrid nonribosomal peptide synthetase/polyketide
synthase machinery. We further demonstrate that
carbamoyltransferase gene padQ is critical to the for-
mation of padanamide A but dispensable for biosyn-
thesis of padanamide B. Biochemical investigations
show that PadQ carbamoylates the rare biosynthetic
precursor L-2,4-diaminobutyrate, generating L-2-
amino-4-ureidobutyrate, the presumed precursor to
the C-terminal residue of padanamide A. By contrast,
the C-terminal residue of padanamide B may derive
from glutamine. An unusual thioesterase-catalyzed
cyclization is proposed to generate the S-Aopc/S-
Apd heterocycles.
INTRODUCTION
Discovery of novel compounds with pharmaceutical potential
from marine sources has received increased attention in recent
years (Gerwick and Moore, 2012). The marine actinomycetes,
in particular, have emerged as a promising resource, producing
novel natural products with unusual chemical structures and
various biological activities (Hughes and Fenical, 2010).
Recently, Streptomyces sp. RJA2928 (Williams et al., 2011), a
strain isolated from sediment in the Pacific Ocean, near Padana
Nahua in Papua NewGuinea, has emerged as an exciting source
for new molecules. The strain produces a series of polyketides,
including the nahuoic acids (Williams et al., 2013), along with
padanamides A and B (Williams et al., 2011), which are highly
modified linear tetrapeptides (Figure 1A). The padanamides
lack any proteinogenic amino acids and possess substructures
that have not been previously reported in the natural products1002 Chemistry & Biology 20, 1002–1011, August 22, 2013 ª2013 Elliterature. It is interesting that a compound identical to padana-
mide A, named actinoramide A (Nam et al., 2011), was indepen-
dently reported fromStreptomyces sp. CNQ-027. This actinomy-
cete strainwas isolated fromsediment on the opposite side of the
PacificOcean, near SanDiego, CA, suggesting a potentially wide
distribution of the padanamides/actinoramides. It is intriguing
that, whereas padanamide A and actinoramide A are identical,
the minor compounds (actinoramides B and C) co-isolated
from Streptomyces sp. CNQ-027 are unique (Figure 1A). Total
synthesis of padanamides A and B was recently reported (Long
et al., 2013), confirming the previous structural elucidations.
The padanamides attracted our attention for their many
unusual chemical features. In particular, the (S)-3-amino-2-oxo-
pyrrolidine-1-carboxamide (S-Aopc) and (S)-3-aminopiperidine-
2,6-dione (S-Apd) residues at the C termini of padanamides A
and B, respectively, are unprecedented in naturally occurring
peptides and lack a clear biosynthetic origin. Other unusual
structural features for padanamides include an N-terminal
methoxyacetyl group and a 4-amino-3-hydroxy-2-methyl-
5-phenylpentanoic acid (Ahmpp) residue. 3-hydroxyleucine
(Hleu) and piperazate (Piz) are also rare, nonproteinogenic
peptidic building blocks. Padanamide B displays cytotoxicity
against Jurkat T lymphocyte cells, with a half maximal inhibitory
concentration value of 20 mg/ml, while padanamide A is roughly
3-fold less active in the same assay (Williams et al., 2011). A
chemical genomics analysis using yeast deletion mutants sug-
gests that padanamide A is involved in the inhibition of cysteine
and methionine biosynthesis or that these amino acids are
involved in the yeast’s response to the peptide. By contrast,
padanamide B does not exhibit the same activity at the concen-
tration where padanamide A is active (Williams et al., 2011). As
padanamides A and B differ only in their corresponding C-termi-
nal residues, these biological data suggest that the unusual
C-terminal residues of padanamides are quite important to their
biological activities. Even more intriguing, the positioning of the
S-Aopc and S-Apd residues at the C termini of the correspond-
ing peptides suggests that elucidation of the responsible genes
and enzymes might enable new strategies for combinatorial
biosynthesis of linear peptides with new C-terminal modifica-
tions (Menzella and Reeves, 2007).
Here, we report the biosynthetic gene cluster of padanamides
from Streptomyces sp. RJA2928. In our work, systematic gene
inactivation mutants are used to delineate the padanamide
gene cluster. Our results reveal a hybrid nonribosomal peptide
synthetase/polyketide synthase (NRPS/PKS) system for assem-
bly of the padanamide skeleton, along with a number of enzymessevier Ltd All rights reserved
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Figure 1. Padanamide Biosynthetic Pathway
(A) Structures of padanamides and actinoramides.
(B) Padanamide biosynthetic gene cluster.
(C) Proposed biosynthetic route to the padanamides and actinoramides. (i) Hybrid NRPS/PKS assembly of the N-terminal aa of the padanamides. (ii) Biosynthesis
of methoxymalonyl-PadG (top) and L-Aub (bottom). (iii) Biosynthesis of L-Dab and N-acetyl-L-2,4-diaminobutyrate from L-aspartate-4-semialdehyde. (iv) For-
mation of padanamide A, padanamide B, and actinoramide B using TE-catalyzed cyclization with amide nitrogens as nucleophiles.
See also Figure S1 and Table S2.
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Padanamide Biosynthetic Gene Clusterbelieved to be involved in the formation of unusual building
blocks. Notably, further in vitro biochemical characterization re-
veals a carbamoyltransferase that catalyzes the transformationChemistry & Biology 20, 1002–of L-2,4-diaminobutyrate (L-Dab) to L-2-amino-4-ureidobutyrate
(L-Aub), which is a key step in the biosynthesis of the S-Aopc res-
idue of padanamide A.1011, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1003
Table 1. Deduced Functions of ORFs of the Padanamide
Biosynthetic Gene Cluster
Gene
Size
(aa)
Homolog and Identity/
Similarity (%)a Proposed Function
orf(2) 3,363 SBI_09160 (YP_
004967409), 78/82
lantibiotic biosynthesis
protein LanM
orf(1) 171 SBI_09159 (YP_
004967408), 75/83
putative type 2
lantibiotic
padF 390 – unknown
padG 104 Npun_F3159 (YP_
001866560), 36/58
discrete ACP
padH 316 QncN (AFJ11257),
65/73
dehydrogenase complex,
E1 component, alpha
subunit
padI 348 QncL (AFJ11255),
55/68
dehydrogenase complex,
E1 component, beta
subunit
padJ 409 Tsn2 (ACR50769),
40/53
dehydrogenase complex,
E2 component
padK 578 PAV_7c00910 (ZP_
10866675), 29/44
FkbH-like protein
padC 1,101 MicvaDRAFT_0252
(ZP_08495279),
38/54
NRPS: C-A-T
padD 1,538 SRIM_23766 (ZP_
20967056), 46/57
PKS: KS-AT-KR-T
padA1 1,116 – NRPS: T-C-A
padB 1,136 AerG1 (ACM68690),
31/47
NRPS: C-A-T
padA2 605 – T-E didomain protein
padM 311 TMO_a0589 (YP_
006373576), 47/57
O-methyltransferase
padL 73 MbtH (YP_006267078),
78/83
MbtH-like protein
padN 448 KtzI (ABV56589),
48/61
ornithine N-hydroxylase
padO 233 Orf4 (ABC56600),
51/62
regulator
padP 281 Orf5 (AAO23330), 31/50 hydroxylase
padE 1,355 MicD (CAQ48261),
29/44
NRPS: C-A-T-TE
padQ 318 Zwa6 (ZP_03234165),
38/56
Asp/OTC
padR 597 SARP regulator (YP_
004967407), 77/84
SARP family regulator
orf(+1) 142 Strvi_4981 (YP_
004814808), 92/95
Asp aminotransferase
See also bioinformatic analysis of PadFKG and PadE-TE in Figure S3.
aParenthetical codes are National Center for Biotechnology Information
accession numbers.
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Padanamide Biosynthetic Gene ClusterRESULTS
Identification of the Padanamide Biosynthetic Gene
Cluster
Retrobiosynthetic analysis of padanamide A (1) suggests that
this tetrapeptide is assembled via a hybrid NRPS/PKS assembly1004 Chemistry & Biology 20, 1002–1011, August 22, 2013 ª2013 Elline from six precursors: (1) 2-methoxyacetate, (2) 3-OH-D-
leucine, (3) Piz, (4) phenylalanine, (5) methylmalonate, and (6)
an unknown molecule that is ultimately converted to the
S-Aopc residue. We thus hypothesized that the padanamide
gene cluster would contain genes for NRPSs and PKSs, along
with accessory genes. Accessory genes would be involved in
the construction of the 2-methoxyacetyl group and might
resemble the starter unit pathway for apoptolidins (Du et al.,
2011). Additionally, an ornithine N-monooxygenase would likely
generate N5-OH-ornithine, the precursor to Piz, as observed in
the biosynthesis of the kutznerides (Fujimori et al., 2007), sangli-
fehrin A (Qu et al., 2011), himastatin (Ma et al., 2011), and other
Piz-containing natural products.
To find the padanamide gene cluster, we initially explored
isolation of adenylation (A) domain and N-oxygenase genes
from RJA2928 genomic DNA using PCR with degenerate
primers. However, we found that Streptomyces sp. RJA2928
genomic DNA contained many distinct A domain and N-oxygen-
ase genes, making this approach inefficient. We thus turned to
genome scanning, assembling 11.3 megabase pairs of nonre-
dundant sequences over 862 contigs with 236-fold read
coverage. Bioinformatic analysis identified one putative biosyn-
thetic gene cluster for padanamides biosynthesis (Figure 1B).
This cluster spans 34.2 kb on a single contig and consists of
19 open reading frames (ORFs), whose deduced functions
are consistent with padanamide biosynthetic pathway. Among
these ORFs, there are four encoding NRPSs, one for a PKS,
and a thiolation-epimerization (T-E) didomain protein, suggest-
ing that an NRPS/PKS hybrid system is involved in padanamide
biosynthesis. Several other genes potentially involved in regula-
tion, starter unit construction, and building block formation are
also observed (Table 1).
Determination of the Gene Cluster Boundaries
To test the necessity of various genes and provide insight into
their roles in biosynthesis of padanamides, we conducted gene
inactivation experiments by using the REDIRECT technique
(Gust et al., 2003; Tables S1 and S2 available online). We first
screened the cosmid genomic library of Streptomyces sp.
RJA2928 and obtained four cosmids that cover part of the pad
cluster. The coverage of each cosmid was identified by end
sequencing or estimated by restriction enzyme digestion pattern
analysis.
Initially, we generated an inactivation mutant in padK (Fig-
ure S1A), which is expected to encode an FkbH-like enzyme,
potentially involved in starter unit construction. The DpadK
mutant lost the ability to produce padanamides (Figure 2A). To
verify that the metabolite profile change was solely due to the
inactivation of this gene, we cloned the coding region of padK
into the integrative vector pYLD20 under the control of the
constitutive promoter ermE*p (Figure S2F). High-pressure liquid
chromatography (HPLC) and liquid chromatography-mass
spectrometry (LC-MS) analysis revealed that reintroduction of
padK restored production of padanamides A and B (Figure S2A).
These data confirm that padK and, by extension, the pad cluster
we identified are responsible for padanamide biosynthesis.
The 30 boundary of the pad cluster is determined by gene inac-
tivation of orf(+1), which is predicted to belong to the aspartate
aminotransferase superfamily. This gene is located 642 basesevier Ltd All rights reserved
Figure 2. Metabolic Analysis of Engineered Strains
(A) Analysis of padanamide production of Streptomyces sp. RJA2928 and its
mutants by HPLC (detection wavelength: 211 nm). The peak corresponding to
the padanamides is marked with a dashed line (padanamides A and B are not
well separated under the current HPLC method). Note that a peak at 14.6 min
is present in all strains, including Streptomyces sp. RJA2928. Precursor
metabolites may be funneled toward this competing biosynthetic pathway in
the absence of a functional padanamide pathway; hence, the increase in
intensity of this nonpadanamide peak when padanamide biosynthesis is
eliminated. AU, absorbance units; std, standard.
(B) Padanamide production from Streptomyces sp. RJA2928 and DpadHIJ,
Dorf(+1), DpadQ, and DpadQ + padQ was further analyzed by LC-MS.
Selective ion monitoring was used to detect the [M+H]+ ion for padanamide A
(m/z = 662) and padanamide B (m/z = 647). The results shows DpadHIJ and
Dorf(+1) produce padanamides A and B normally, while DpadQ only produces
padanamide B.
See also Figure S2 and Table S1.
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Padanamide Biosynthetic Gene Clusterpairs (bp) downstream of putative regulator gene padR, which
encodes a putative SARP-family regulator, a type of regulator
frequently associated with secondary metabolite gene clusters
in Streptomyces (Liu et al., 2013). Our data show that the
Dorf(+1) mutant strain produces padanamides at a titer compa-Chemistry & Biology 20, 1002–rable to that of the parental strain (Figure 2A), indicating that
orf(+1) is outside of the pad cluster. Thus, we propose that
padR is the 30 boundary of the pad cluster. For the 50 boundary
of the pad cluster, we generated the DpadF mutant, which lost
the ability to produce padanamides (Figure 2A). Three hundred
bp upstream of padF are orf(1) and orf(2), which show high
sequence identity (75% and 78%, respectively) to putative
type 2 lantibiotic precursor peptide (SBI_09159) and a lantibiotic
biosynthesis protein LanM (SBI_09160) fromS. bingchenggensis
BCW-1. Given that thewhole genome of RJA2928 exhibits a high
degree of homology with S. bingchenggensis BCW-1, yet
S. bingchenggensis BCW-1 lacks a pad gene cluster, we pro-
pose that orf(1) and orf(2) are involved in biosynthesis of a
natural product distinct from padanamide. Thus, we propose
that padF is the 50 boundary of the pad cluster (Figure 1).
Assembly of the Padanamide Core
All of the four NRPS genes (padA1, padB, padC, and padE) found
in the pad cluster were predicted to encode monomodular
NRPSs. PadA1 contains three typical NRPS domains with the
following arrangement: T domain, condensation (C) domain,
and A domain. By contrast, most NRPS domains have the
following characteristic ordering: C-A-T. Sequence analysis
further reveals that the PadA1-T, which has a conserved serine
residue, may be a truncated T domain. By contrast, the A domain
of PadA1 appears typical, and the sequence of the A domain
specificity ‘‘code’’ (DAWYIGAIVK) suggests that the PadA1
NRPS module will incorporate L-leucine. A T-E didomain protein
PadA2 was also identified in the padanamide gene cluster, and
the presence of an E domain in the cluster agrees with the
occurrence of D-stereochemistry in the Hleu residue in the pada-
namides. Here, the T domain appears to be a typical E-domain-
coupled T, with a well-conserved CoreT sequence, GGDSI
(Linne et al., 2001). We propose that PadA1 and PadA2 collec-
tively form the first NRPS module (C-A-T-E) through protein-
protein interactions, where the initial PadA1-T domain may be
inactive or may act to carry the putative methylacetyl starter
unit (Figure 1C). Splitting of modules across two genes has
been observed previously in zwittermicin A and himastatin
biosynthesis (Kevany et al., 2009; Ma et al., 2011). The involve-
ment of PadA2 in padanamide biosynthesis was confirmed by
in vivo gene knockout and complementation experiments:
padanamide biosynthesis is abolished in DpadA2, and padana-
mide production is restored by provision of padA2 (Figure 2A;
Figure S2E).
The A domain substrate signature of PadB (DVQYMAQVVK) is
most similar to those for proline/pipecolic acid, which are struc-
turally similar to Piz. We thus propose that PadB is responsible
for Piz incorporation. The predicted substrate specificity
(DAWTVAAVAK) of PadC is phenylalanine. PadD is a mono-
modular type I PKS containing four domains: ketosynthase
(KS), acyltransferase (AT), ketoreductase (KR), and T domain.
The predicted substrate for its AT domain is methylmalonyl-co-
enzyme A. The substrate selectivity and domain organization
of padC and padD is consistent with the structure of Ahmpp res-
idue present in padanamides. Finally, a thioesterase (TE) domain
is identified at the C-terminal end of PadE, suggesting that PadE
is the last module in the NRPS assembly line and is responsible
for the peptidyl chain release. Sequence analysis of the A domain1011, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1005
Chemistry & Biology
Padanamide Biosynthetic Gene Clusterof PadE reveals that its substrate signature (DVQDIGCVNK) is
most similar to those of lysine/glutamine-activating A domains.
The likely substrates of PadE are addressed later.
Additionally, padL encodes an MbtH-like protein, which has
been found in many NRPS-encoding gene clusters and shown
to be an integral component of NRPSs (Felnagle et al., 2010).
Overall, this five-module NRPS/PKS assembly line supports
the structure of padanamide core, but one module is split across
two genes, and the arrangement of genes does not abide the
co-linearity rule of classical NRPSs (Marahiel et al., 1997).
Starter Unit Biosynthesis
An N-terminal 2-methoxyacetyl group is present in padana-
mides. A number of methoxyacetyl-containing polyketides
have been shown to use methoxymalonyl as a T-domain-pro-
tein-linked PKS extender unit to elongate the polyketide chain
with a methoxylacetyl unit (Chan et al., 2006; Wu et al., 2000;
Zhao et al., 2006), and recently, one report has described the
use of methoxymalonyl as a starter unit that is ultimately con-
verted to a methoxyacetyl group (Du et al., 2011). In each of
the aforementioned pathways, five genes (fkbGHIJK homologs)
are thought to be involved in the biosynthesis of the methoxy-
malonyl starter unit. At the first step, the enzyme FkbH dephos-
phorylates and covalently tethers the glycolytic substrate
1,3-bisphosphoglycerate to the T domain protein FkbJ, forming
glyceryl-FkbJ (Chan et al., 2006). After the oxidation of glyceryl-
FkbJ to hydroxymalonyl-FkbJ catalyzed by FkbK and FkbI,
FkbG catalyzes the finalO-methylation to generate methoxyma-
lonyl-FkbJ (Chan et al., 2006). However, only a subset of these
genes is present in the padanamide cluster. There is a free-
standing T domain protein (PadG), an atypical FkbH-like protein
(PadK) (Figure S3A), and an O-methyltransferase (PadM), which
are functional equivalents to FkbJ, FkbH, and FkbG, respec-
tively. Additionally, the padanamide pathway has an additional
protein, PadF, whose N terminus has sequence similarity to
N-terminal extensions of several enzymes that also contain
FkbH domains, suggesting that PadF may play an accessory
role to PadK (Figure S3B). However, FkbK and FkbI homologs
are absent from the padanamide gene cluster, as is the KSQ
thought to be involved in conversion of the methoxymalonyl
group to a methoxyacetyl group (Du et al., 2011).
To assess which gene(s) are responsible for formation of the
starter unit, we constructed in-frame deletion mutants of padF,
padG, padM, and padK. No padanamides were observed from
HPLC analysis of the culture extracts from DpadF, DpadG,
DpadK, and DpadM mutant strains (Figure 2A), demonstrating
that each of the encoded enzymes are necessary for padana-
mide construction. The aforementioned bioinformatic analysis,
as well as in vivo gene inactivation results, suggests that the
incorporation of methoxyacetyl unit may share some of the steps
for biosynthesis of methoxymalonyl unit previously described for
PKS systems. In particular, glyceryl-PadG formation by PadK
and PadF could be the initial step of padanamide biosynthesis,
and PadM could catalyze the O-methylation step. However,
our current data give no clue about how the intermediate step
of conversion of glyceryl-ACP to hydroxymalonyl-PadG is car-
ried out. It is possible that genes outside the pad cluster
participate in this process, as two additional sets of fkbGHIJK
homologs are identified in the genome. However, in this case,1006 Chemistry & Biology 20, 1002–1011, August 22, 2013 ª2013 Elthe padKmutant itself may not be complemented, as observed,
as PadK is an ‘‘atypical’’ FkbH homolog (Figure S3A), which dif-
fers from the classic FkbH family members with an additional
N-terminal extension (260 amino acids [aa]). In the tetronomyin
pathway, Sun et al. showed that PadK’s homolog Tmn16 needs
its N-terminal domain for functional integrity and the Tmn16-
Tmn7a (cognate T domain protein) interaction is specific (Sun
et al., 2008). PadKmay thus require a specific cognate T domain
protein (PadG) and accessory protein (PadF). Furthermore, the
timing of methylation by PadM is unknown. Hence, the padG,
padF, and padM mutants may not be complemented by exoge-
nous fkbGHIJK genes. Finally, conversion of the final methoxy-
malonyl-PadG to methoxyacetyl-PadG is unknown, as no genes
could be linked to this step. Another possible scenario to
account for precursor construction is that a previously unde-
scribed pathway gives rise to the methoxyacetyl precursor. All
our efforts to obtain soluble PadKwere unsuccessful, and details
of the initial step remain to be established.
Embedded between padG (encoding a T domain protein) and
padK (encoding an FkbH-like enzyme) are padH, padI, and
padJ (padH-I-J). PadH, PadI, and PadJ are not related to Fkb
enzymes: PadH and PadI are instead highly related to recently
characterized QncN and QncL (Table 1), respectively, from the
quinocarcin biosynthetic pathway (Peng et al., 2012). QncN
and QncL have been shown to catalyze the transfer of a C2
unit from ketose to a cognate T domain protein QncM to form
glycolicacyl-ACP as an extender unit for an NRPS. The transcrip-
tion of padFGHIJKCD appears to be coupled due to overlapping
stop and start codons. It is unexpected to observe genes that are
potentially involved in the biosynthesis of the N-terminal methox-
ylacetyl group from two different pathways for incorporating
two-carbon units. We constructed a deletion mutant of the entire
padH-I-J, and we observed that production of padanamides
in DpadH-I-J mutants remained nearly unaffected (Figure 2),
demonstrating that padH-I-J are not involved in padanamide
production.
Additional Precursor Biosynthesis and Regulation
The gene product of padP (281 aa) belongs to the 2-oxoglutarate
and Fe(II)-dependent oxygenase superfamily (Pfam ID 13640)
and shows 27% sequence identity with LdoA, recently charac-
terized as an Fe(II)/a-ketoglutarate-dependent L-leucine 5-hy-
droxylase (Hibi et al., 2013). Sequence alignment reveals that
both LdoA and PadP contain a conserved histidine (His)2-aspar-
tate (Asp) facial triad (H167, D169, and H251 for PadP) involved
in Fe(II) binding as well as the basic residue (R262 for PadP) that
binds to a-ketoglutarate. PadP is likely to catalyze a related reac-
tion, i.e., 3-hydroxylation of L-leucine. We constructed DpadP
and confirmed by HPLC analysis of the crude extracts that pada-
namide production was eliminated (Figure 2A), definitively linking
PadP to the biosynthesis of padanamides. Furthermore, selec-
tive ion monitoring by MS failed to detect the target ion for dehy-
droxypadanamide A or B for the DpadP mutant, indicating that
the b-hydroxylation on leucine of padanamide is likely to occur
on the NRPS assembly line rather than after release of the pep-
tide chain from the NRPS.
The gene product of padN is homologous to various lysine/
ornithine monooxygenases, and its homologs have been found
in the biosynthetic gene clusters of kutznerides, himastatin, andsevier Ltd All rights reserved
Figure 3. Bioinformatic Analysis of PadQ
(A) Sequence alignment of PadQ with ornithine
and L-Dap carbamoyltransferases. HumOTC,
human OTC (AAI07154); MtbOTC, Mycobacte-
rium tuberculosis OTC (UniProtKB/Swiss-Prot:
P0A5M8.1); PfuOTC, Pyrococcus furiosus OTC
(X99225); and EcoOTC, Escherichia coli OTC
(YP_003937659). Boxes indicate the conserved
carbamoyl phosphate binding motif STRTR and
the ornithine-binding motifs DXXXSMG and HCLP
for OTC. VioL (AAP92502), CmnL (ABR67755),
and ZmaT (ACM79819) are the putative L-Dap
carbamoyltransferases from viomycin, capreo-
mycin, and zwittermicin A biosynthetic pathways,
respectively.
PfuOTC, Pyrococcus furiosus OTC (X99225).
(B) Phylogenetic analysis of PadQ with its homo-
logs. Their substratesare indicatedat the right side.
See also Figure S5.
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Padanamide Biosynthetic Gene Clustersanglifehrin, all of which contain Piz (Fujimori et al., 2007; Ma
et al., 2011; Qu et al., 2011). KtzI, the homolog from the kutzner-
ide gene cluster, has been recently defined as an ornithine
N-hydroxylase, which catalyzes the conversion of ornithine to
N5-OH-ornithine (Neumann et al., 2012). Furthermore, N5-OH-
ornithine was identified as an early intermediate in Piz biosyn-
thesis by isotopic-labeling experiments (Neumann et al.,
2012). These data suggest that PadN could be involved in the
production of the Piz residue of padanamides in a similar
manner.
The gene padR encodes a putative SARP family regulator, and
SARP family regulators are frequently found to be associated
with a secondary metabolite gene clusters in Streptomyces
(Liu et al., 2013). Additionally, there appears to be a second
regulator in the padanamide pathway, encoded by padO.
PadO contains an FMN binding domain (Pfam ID 04229),
showing homology to PaiB, which is a transcriptional regulator
negatively controlling sporulation in Bacillus subtilis (Honjo
et al., 1990). Although the detailed mechanism for this family
of regulators is still unknown, recent structural analysis of a ho-
molog from Geobacillus stearothermophilus revealed a likely
C-terminal helix-turn-helix DNA binding domain, suggesting
that these regulators may act as DNA-binding transcriptional
regulators (Filippova et al., 2011). We constructed DpadO and
its complemented mutant (Figure 2A; Figure S2C), and the
HPLC results showed that the DpadO mutant abolished pada-
namide production, indicating that it probably acts as a pathway
activator. PadO also has sequence identity of 51% to Orf4 of the
kutzneride gene cluster (Fujimori et al., 2007) and 45% to SfaC
of the sanglifehrin gene cluster (Qu et al., 2011). Both Orf4 and
SfaC are annotated as putative regulators; however, no genetic
evidence is available. Our genetic results indicate that PadO and
its homologs may represent a novel family of transcriptional reg-
ulators that control the biosynthesis of some secondary
metabolites.Chemistry & Biology 20, 1002–1011, August 22, 2013 ªBiosynthesis of S-Aopc and S-Apd
1 is the major padanamide (92%) rela-
tive to 2 (8%) in wild-type Streptomyces
sp. RJA2928. The difference between themolecules is in the C-terminal residue, where the S-Aopc residue
in 1 differs from the S-Apd in 2 via both an altered cyclization and
the formal addition of an ‘‘NH.’’ Both substructures are unique in
the natural products literature. From a biosynthetic point of view,
two pathways could be envisioned to account for these twomol-
ecules. A first possibility is that padanamide B could represent a
biosynthetic intermediate that undergoes further conversions to
give padanamide A. The second possibility is that alternate aa
are loaded and cyclized by a nonribosomal synthetase module,
with preference given to the precursor that leads to S-Aopc.
The gene padQ, putatively encoding a carbamoyltransferase,
attracted our attention. In the DpadQ mutant, padanamide B
production increased more than 5-fold, with a complete loss in
padanamide A production. Production of padanamide A can
be restored by complementation in trans (Figures 2A and 2B).
This result unambiguously connects padQ to the formation of
the unique S-Aopc residue in padanamide A.
PadQ is predicted to be a putative ornithine carbamoyltrans-
ferase (OTC), containing two putative domains: the N-terminal
carbamoyl phosphate-binding domain and the C-terminal
ornithine-binding domain. OTCs catalyze the carbamoylation
of L-ornithine to form L-citrulline. There is a carbamoyl group in
S-Aopc of padanamide A; however, L-citrulline itself cannot be
converted to S-Aopc, as it has an additional methylene group
relative to S-Aopc. Instead, carbamoylation of L-Dab, with one
less methylene than L-ornithine, could sensibly give this struc-
ture. We speculated that the putative carbamoylated product
of L-Dab, i.e., L-Aub, could be activated and cyclized to give
rise to S-Aopc. Bioinformatic analysis of PadQ shows that
PadQ has the characteristic STRTR sequence for carbamoyl
phosphate binding seen in OTCs (Sankaranarayanan et al.,
2008). However, unlike OTCs that have ornithine-binding motifs
DXXXSMG and HCLP, PadQ shows deviations in this strictly
conserved region: DXXXSMG is replaced by TRWQSMG and
HCLP is replaced by HDLP (Figure 3A), suggesting that the2013 Elsevier Ltd All rights reserved 1007
Figure 4. In Vitro Analysis of Carbamoyl-
transferase PadQ
(A) Purification of PadQ from Rhodococcus sp.
RHA1.
(B) Monitoring of PadQ-catalyzed carbamoylation
of L-Dab by TLC.
(C) Analysis of PadQ-catalyzed carbamoylation of
L-Dab (indicated by DAB) by LC-MS analysis
monitoring the [M+H]+ ion for L-Dab (m/z = 119)
and L-Aub (m/z = 162). (i) L-Dab + CP + Boiled
PadQ (20 min), (ii) L-Dab + CP + PadQ (0 min), (iii)
L-Dab + CP + PadQ (2.5 min), (iv) L-Dab + CP +
PadQ (5 min), (v) L-Dab + CP + PadQ (10 min), and
(vi) L-Dab + CP + PadQ (20 min). AUB, L-Aub.
(D) NMR analysis of purified L-Aub.
See also Figure S4.
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highlight related changes in these two sites for putative L-2,3-di-
aminopropionate (L-Dap) carbamoyltransferases (Barkei et al.,
2009). In these enzymes, DXXXSMG is replaced by (S/T)
RWQTTG and HCLP is replaced again by HDLP. L-Dap is two
methylene groups shorter than L-ornithine (Figure 3B).
Initially, we attempted to purify PadQ from recombinant
expression of padQ in E. coli, but we were unable to obtain sol-
uble protein. Instead, we overexpressed PadQ as a His-tagged
fusion protein in Rhodococcus sp. RHA1 and purified it to homo-
geneity (Figure 4A). We first tested L-Dab as a substrate for
PadQ. We incubated L-Dab with carbamoyl phosphate (CP)
and PadQ, and the reaction mixture was analyzed by thin-layer
chromatography (TLC) and visualized with ninhydrin. As shown
in Figure 4B, a new alpha amino acid appears that depends on
CP and active PadQ. Full conversion of L-Dab to the new product
is observed after 20 min of incubation. LC-MS analysis was then
used to monitor the [M+H]+ ion for L-Dab (mass-to-charge ratio
[m/z] = 119) and L-Aub (m/z = 162), which is the expected product
of PadQ-catalyzed carbamoylation of L-Dab (Figure 4C). The
result shows that the ion signal for protonated L-Dab declines
over incubation time, while a new, PadQ-dependent ion signal
(m/z 162) increases, in a manner highly consistent with the TLC
data. To further confirm that the new compound observed on
TLC plate is L-Aub, we purified this enzymatic product to homo-
geneity by repeated preparative TLC on silica gel and subjected
to HRESIMS and tandem MS (MS/MS) analysis. The purified
compound gave an [M+H]+ ion in the HRESIMS at m/z
162.0879, consistent with the molecular formula of C5H11N3O3
for L-Aub (calculated for C5H12N3O3, 162.0879) (Figure S4A).
MS/MS analysis produced an ion at m/z 145, which could be
due to the loss of ammonia from the [M+H]+ ion, and higher frag-
mentation energy caused full conversion of m/z 162 to m/z 145.
Further fragmentation of the ion at m/z 145 gave both an ion at
m/z 99 and 101, likely corresponding to the loss of, respectively,
formic acid and CO2 from the [M+H-NH3]
+ ion (Figure S4A). The
structure of L-Aub is consistent with all the ion species arising1008 Chemistry & Biology 20, 1002–1011, August 22, 2013 ª2013 Elsevier Ltd All rights resefrom the fragmentation. Using nuclear
magnetic resonance (NMR) experiments
(Figures S4B–S4E), the structure of this
compound was unambiguously eluci-
dated to be L-Aub (Figure 4D). Overall,these data support the conclusion that PadQ catalyzes the
transfer of the carbamoyl group of CP to L-Dab, resulting in
L-Aub. To further test the substrate selectivity for PadQ, we
instead tested L-ornithine, L-lysine, L-asparagine, and L-gluta-
mine in the reaction mixture; however, no carbamoyltransferase
activity was noted for any of these substrates in the reaction
conditions we used (Figure S5).
L-Dab is a rare biosynthetic precursor; however, it is generated
in halophilic bacteria as an intermediate on the route to ectoine,
which serves as compatible solute and is used to counteract
high osmolarity (Louis and Galinski, 1997). The first conversion
in this three-enzyme pathway is the conversion of L-aspartate-
4-semialdehyde to L-Dab, catalyzed by EctB (Louis and Galinski,
1997). A number of nonribosomal peptides have been found
to use L-Dab as a direct building block for NRPSs, such as
cupriachelin (Kreutzer et al., 2012), pyoverdines (Mossialos
et al., 2002), syringopeptin (Scholz-Schroeder et al., 2003), and
polymyxin (Choi et al., 2009). In polymyxin production, a single
ectB gene is found in the polymyxin producer, outside of
the polymyxin gene cluster, and heterologous production of
polymyxin requires provision of either ectB or L-Dab itself.
We observed that padanamide producer Streptomyces sp.
RJA2928 has a typical ectABC gene cluster, as well as an addi-
tional orphan ectB gene outside the pad cluster. One or both of
these EctBs is likely to provide endogenous L-Dab to the pada-
namide pathway (Figure 1C), where it is converted to L-Aub by
PadQ (Figure 1C).
Once generated, L-Aub can be loaded on to the T domain of
PadE, the terminal NRPS in the padanamide pathway. An intra-
molecular, TE-catalyzed cyclization, using the secondary amide
nitrogen of L-Aub as a nucleophile, could release the nascent
padanamide A, forming the unusual S-Aopc residue. By
contrast, generation of padanamide B could instead arise from
a similar cyclization of glutamine. Here, intramolecular nucleo-
philic attack of the Nε of glutamine on the carbonyl of a tethered
linear intermediate could release the nascent padanamide B,
forming S-Apd (Figure 1C). The presence of different C-terminalrved
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substrate specificity of the A domain of PadE.
DISCUSSION
In this work, we isolate the padanamide gene cluster. Using
comprehensive gene inactivation experiments, we were able to
delineate the boundaries of the padanamide gene cluster and
propose a biosynthetic pathway for padanamides A and B.
Our work primarily addresses the origin of the unusual amino
acid S-Aopc in padanamide A. Targeted inactivation of padQ
abolishes production of padanamide A and promotes the pro-
duction of padanamide B. These results unequivocally link
padQ to padanamide A production and demonstrate that it is
dispensable to production of padanamide B. Initial bioinformatic
annotation suggested that padQ encodes an OTC. Nonetheless,
we observe that conserved residues related to specificity for
ornithine were altered in PadQ, suggesting that a unique sub-
strate may be taken up by PadQ. We further pursued biochem-
ical analysis of this enzyme, revealing that the substrate
accepted by PadQ is L-Dab, which is carbamoylated by PadQ
to give L-Aub. We propose that this unusual amino acid could
then be activated as a thioester intermediate on the correspond-
ing NRPS PadE and undergo an unusual intramolecular cycliza-
tion, with an amide nitrogen on the loaded amino acid acting as a
nucleophile. Finally, we address the origin of the PadQ substrate
L-Dab: the genome of Streptomyces sp. RJA2928 has two ectB
homologs. Encoded enzymes putatively convert L-aspartate-4-
semialdehyde to L-Dab, suggesting a reasonable route for provi-
sion of L-Dab to the padanamide pathway.
Prior to our study, two pathways might have been envisioned
to account for production for the S-Aopc in padanamide A and
the S-Apd in padanamide B. The first possible pathway is one
where padanamide B is a metabolic intermediate, which is off-
loaded from the NRPS and undergoes further enzyme-catalyzed
conversions to generate padanamide A. In this case, unusual
enzymatic conversions would be required. The second possible
route to the padanamides is the loading of alternate aa to give
padanamides A and B on a promiscuous NRPS. This scenario
could reasonably give rise to padanamide B by loading and cycli-
zation of glutamine to give S-Apd, an idea that is partially
supported by the predicted A domain substrate specificity of
PadE. However, the problem with this scenario was that there
is no common amino acid likely to give padanamide A. Our
work has demonstrated that the second scenario, i.e., a promis-
cuous NRPS, is used in padanamide biosynthesis and that the
C-terminal residue of padanamide A derives from L-Aub. Based
on our results, we support the hypothesis that PadE is a promis-
cuous enzyme, which has a preference for L-Aub but will also
accept glutamine. Rather than being a metabolic intermediate
or shunt product, padanamide B is then an alternate product
of the same biosynthetic pathway.
Padanamides were reported almost simultaneously with the
actinoramides (Nam et al., 2011), which were isolated from
Streptomyces sp. CNQ-027, another strain derived from sedi-
ment of the Pacific Ocean. Actinoramide A, the major actinora-
mide, is identical to padanamide A. By contrast, the minor
actinoramides are distinct: actinoramide B has another unique
C-terminal residue, (S)-1-acetyl-3-aminopyrrolidin-2-one, andChemistry & Biology 20, 1002–actinoramide C is a truncated structure compared to all other
structures. Actinoramide C presumably derives from an unusual,
premature off-loading of an actinoramide intermediate from the
PKS related to PadD in the actinoramide pathway. By contrast,
actinoramide B may derive from loading and cyclization of
another amino acid. The (S)-1-acetyl-3-aminopyrrolidin-2-one
residue in actinoramide B is the acetylated derivative of
S-Aopc in padanamide A, and like the S-Aopc in padanamide
A, this residue may derive from an ectoine biosynthetic interme-
diate. In the ectA-B-C-encoded pathway for ectoine, L-Dab is
further processed to N-acetyl-L-2,4-diaminobutyrate by EctA
(Figure 1C) (Louis and Galinski, 1997). Loading and cyclization
of N-acetyl-L-2,4-diaminobutyrate by a PadE-homolog could
generate the (S)-1-acetyl-3-aminopyrrolidin-2-one residue in ac-
tinoramide B in a similar fashion to that proposed for S-Aopc in
padanamide A (Figure 1C). Thus, actinoramide B represents a
possible third final product of the padanamide biosynthetic
machinery. However, the actinoramide gene cluster in Strepto-
myces sp. CNQ-027 has not yet been identified. Whether this
gene cluster is indeed highly related, and whether there is an
exogenous ectoine pathway in Streptomyces sp. CNQ-027,
remains to be established.
Our biosynthetic proposal suggests that padanamide A,
padanamide B, and actinoramide B derive from an unusual,
TE-catalyzed cyclization. Typically, TE-catalyzed chain release
mechanisms include hydrolysis (intermolecular release) and
macrocyclization (intramolecular release) (Du and Lou, 2010).
For hydrolysis, water acts as the nucleophile to attack the
carbonyl carbon of the acyl or peptidyl-O-TE and release a linear
product. For macrocyclization, a hydroxyl or an amino group of
the acyl or peptidyl chain acts as an internal nucleophile to attack
the carbonyl carbon of the acyl or peptidyl-O-TE and a cyclic
product is released. Typically, the nucleophile is in an amino
acid earlier in the peptide chain (Du and Lou, 2010), but recently,
a number of siderophores have been isolated that have either a
C-terminal cyclic Nd-OH-ornithine (Kodani et al., 2013; Kreutzer
and Nett, 2012; Mazzei et al., 2012; Seyedsayamdost et al.,
2011) or a C-terminal cyclic Nε-OH-lysine (Hoshino et al.,
2011). In these cases, the hydroxylamine of the C-terminal
Nd-OH-ornithine or Nε-OH-lysine is thought to be used as a
nucleophile to generate small, N-heterocycles and release linear
peptides. The padanamides represent a further extension of this
modification. Again, small heterocycles are generated through
the use of a nucleophile from within the last appended amino
acid. In padanamide biosynthesis, however, we speculate that
an amide nucleophile—rather than an amine nucleophile—is
used. Amide-based nucleophiles have been previously pro-
posed in the biosynthesis of spirolactams in sanglifehrin A (Qu
et al., 2011) but have not been proposed for release of linear pep-
tides from NPRS machinery. Nonetheless, we favor this unusual
use of an amide nucleophile, as it nicely accounts for provision of
padanamide A, padanamide B, and actinoramide B. However,
the details of the proposed TE-catalyzed cyclization remain to
be investigated: neither full-length PadE nor truncated PadE-T-
TE could be purified from heterologous expression systems
(i.e., E. coli, Rhodococcus), including coexpression with PadL,
the MbtH-like protein. Additionally, soluble PadE-A could not
be obtained from either E. coli or Rhodococcus. Thus, both the
complete inventory of amino acid preferences of PadE and the1011, August 22, 2013 ª2013 Elsevier Ltd All rights reserved 1009
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remain to be established. Bioinformatic analysis of the PadE-
TE does not reveal any obvious differences from other TE do-
mains, except its relatively large size (Figures S3C and S3D).
Our work has investigated the unusual biosynthetic pathway
to the highly modified linear peptides padanamides. We isolated
the padanamide gene cluster, established the cluster bound-
aries, and carried out systematic gene inactivation experiments.
Our work pinpointed padQ, encoding a carbamoyltransferase,
which we biochemically characterized and demonstrated is
critical to the outcome of the padanamide biosynthetic path-
way. Furthermore, most intriguing is the enzyme PadE. PadE
apparently catalyzes an intramolecular cyclization on multiple
substrates using amide-based nucleophiles within the last ap-
pended amino acid, generating small, 5- or 6-membered ring
heterocycles and releasing linear peptides. Although PadE itself
could not yet be purified, PadE homologs mined from genomic
data may represent exciting starting points for further biochem-
ical investigation of this potentially unusual TE-catalyzed enzy-
mology. Furthermore, padE or its engineered derivatives may
find application in the combinatorial generation of new linear
peptides with C-terminal heterocyclic residues.
SIGNIFICANCE
Secondary metabolites are the source for some of the most
unusual structures in the chemistry literature. One biological
strategy to generate novel molecules is to bring together
enzymatic machinery from disparate sources. Here, we
identify the biosynthetic machinery responsible for pro-
duction of the padanamides. The padanamides possess
C-terminal heterocycles that are unprecedented in the liter-
ature. Through our systematic gene inactivation, metabolic
profiling, and biochemical experiments, we identify a
three-step strategy to generate the unusual C-terminal het-
erocycle found in padanamide A. This strategy involves,
first, interception of L-Dab, an intermediate from the ectoine
pathway; second, N-carbamoylation of L-Dab; and third,
putatively, a unique NRPS-catalyzed loading and cyclization
mechanism. The interception of L-Dab by an N-carbamoyl-
transferasehasnotbeenpreviouslyobserved,and the result-
ing product L-Aub has not been previously encountered in a
natural product. Small changes in the amino acid sequence
of the N-carbamoyltransferase PadQ, compared to more
common OTCs, have apparently enabled this enzyme to
react with L-Dab rather than ornithine. Yet, the presence or
absence of this enzyme reroutes the outcome of the entire
padanamide biosynthetic pathway. Our work provides mo-
lecular insights into the biosynthesis of two unprecedented
heterocycles, and new genes identified from this pathway
will enrich the toolbox for combinatorial biosynthesis.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for bacterial strains, plasmids,
and culture conditions; genome scanning and in silico analysis; construction
and screening of a Streptomyces sp. RJA2928 genomic cosmid library; gener-
ation of mutant strains of Streptomyces sp. RJA2928; cloning, expression, and
purification of recombinant PadQ; and structure elucidation of enzymatically
produced L-Aub.1010 Chemistry & Biology 20, 1002–1011, August 22, 2013 ª2013 ElAnalysis of Padanamides Production in Streptomyces sp. RJA2928
Streptomyces sp. RJA2928 was cultured on 350 ml of solid MM1 agar (Wil-
liams et al., 2011). After 10 days of growth at 30C, the agar was cut into small
pieces, combined, and extracted with ethyl acetate. The extract was dried
under vacuum and dissolved in 2 ml of acetonitrile. HPLC analysis was carried
out with an Agilent 1260 HPLC apparatus with a diode array UV detector, fitted
with an Agilent Zorbax 300SB-C18 column (5 mm, 4.6 mm3 250 mm). Elution
was performed at 1 ml/min with a mobile-phase mixture consisting of a linear
gradient of water and acetonitrile (85:15 to 60:40, 0 to 15 min; 60:100, 15 to
18 min; 0:100, 18 to 20 min), both of which contain 0.05% (v/v) trifluoroacetic
acid. Padanamides A and B standard compounds were used as a control. LC-
MS was performed under the same conditions on an Agilent 6120 Quadruple
LC/MS system operated in both positive and negative ion electrospraymodes.
In Vitro Enzyme Assay of PadQ
In a typical reaction, 1 mM of recombinant PadQ was reacted with 5 mM car-
bamoyl phosphate and 2 mM L-Dab at 30C in 50 mM Tris-HCl buffer (pH 8.3)
in a total volume of 1 ml. The reactions were initiated by the addition of carba-
moyl phosphate, and quenched at different times by the addition of 1 ml cold
methanol. As a control, PadQ that had been boiled for 10 min was used under
identical reaction condition. After being passed through a 0.22-mm filter, reac-
tionmixtures were spotted on TLC plates (Silica gel, Sigma-Aldrich) and devel-
oped with butanol/acetic acid/water (6:2:1). Visualization of the spots on TLC
plate was performed by spraying with ninhydrin reagent (0.5% (w/v) ninhydrin
and 1% (v/v) acetic acid in butanol). For LC-MS, 10 ml of each reaction solution
was loaded on Agilent 6120 Quadruple LC/MS system (column: Econosil C8,
4.6 mm 3 250 mm, 5 mm) with the following gradient: solvent A: water (0.05%
(v/v) trifluoroacetic acid), solvent B: acetonitrile (0.05% (v/v) trifluoroacetic
acid), flow rate: 0.6 ml/min, gradient: 100:0, 0 to 5 min; 90:10, 5 to 10 min,
0:100, 10 to 12 min; 100:0, 12 to 15 min. Protonated L-Dab has an m/z of
119, and protonated L-Aub has an m/z of 162.
ACCESSION NUMBERS
The sequence of the padanamide gene cluster is accessible at GenBank under
accession number KC915040. Additionally, sequences of the ectoine gene
cluster (accessionnumberKF177908), stand-aloneectBgene (accessionnum-
ber KF177909), and two fkbGHIJK clusters (accession numbers KF177906 and
KF177907) in Streptomyces sp. RJA2928 are accessible at GenBank.
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